Laxido

Macrogol 3350, the active ingredient in Laxido, is an osmotic laxative presented as an oral solution for oral use. It is indicated for the relief of constipation in adults and children, helping to soften stool and promote regular bowel movements.

GNH USA supplies Laxido as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, including temperature‑controlled shipping where required, and comprehensive regulatory support globally.

Laxido, an osmotic laxative, acts on the gastrointestinal tract to alleviate constipation.

Constipation: softens stool and facilitates regular bowel movements in patients with functional constipation. Functional constipation: increases stool water content to improve frequency and ease of passage. Opioid‑induced constipation: counteracts reduced intestinal motility caused by opioid therapy.

Laxido may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating - Flatulence - Nausea - Diarrhea

Serious or Rare Side Effects: - Severe electrolyte imbalance - Marked dehydration - Allergic reactions (rash, angioedema)

Before using Laxido, consider the following precautions.

Assess renal function: evaluate kidney status before initiating therapy in patients with renal impairment. Monitor electrolytes: check serum electrolytes periodically during prolonged use. Use cautiously in bowel obstruction: avoid if mechanical obstruction is suspected. Adjust dose in elderly: start with lower volume to reduce risk of dehydration. Avoid in known hypersensitivity: discontinue if allergic reaction occurs. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Laxido can interact with other medicines; review the following.

Major Interactions (Avoid): - Concomitant use with other osmotic laxatives: risk of severe electrolyte disturbances. - Loop diuretics: increased risk of dehydration and electrolyte loss. - Mineral oil: may reduce efficacy of macrogol.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may diminish laxative effect. - NSAIDs: potential additive gastrointestinal irritation. - Calcium supplements: may interfere with stool water binding.